logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Resistance To Anticancer Therapeutics Targeting Receptor Tyrosine Kinases And Downstream Pathways 1st Ed Yosef Yarden

  • SKU: BELL-7147290
Resistance To Anticancer Therapeutics Targeting Receptor Tyrosine Kinases And Downstream Pathways 1st Ed Yosef Yarden
$ 31.00 $ 45.00 (-31%)

4.4

52 reviews

Resistance To Anticancer Therapeutics Targeting Receptor Tyrosine Kinases And Downstream Pathways 1st Ed Yosef Yarden instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 4.94 MB
Author: Yosef Yarden, Moshe Elkabets
ISBN: 9783319679303, 9783319679327, 3319679309, 3319679325
Language: English
Year: 2018
Edition: 1st ed.

Product desciption

Resistance To Anticancer Therapeutics Targeting Receptor Tyrosine Kinases And Downstream Pathways 1st Ed Yosef Yarden by Yosef Yarden, Moshe Elkabets 9783319679303, 9783319679327, 3319679309, 3319679325 instant download after payment.

This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.

Related Products